Showing results (61-70 of 124) with videos related to
Sort By:
Pageof 13
Journal of Virology|August 10, 2012
HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteinsYuxing Li, Sijy O'Dell, Richard Wilson, et al.Journal of Virology|September 27, 2003
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2Christiana Iyasere, John C Tilton, Alison J Johnson, et al.Plos One|December 13, 2019
Toll-like receptor 7-adapter complex modulates interferon-α production in HIV-stimulated plasmacytoid dendritic cellsAndy A Patamawenu, Nathaniel E Wright, Tulley Shofner, et al.Plos One|June 15, 2016
Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8Cinque Soto, Gilad Ofek, M Gordon Joyce, et al.JCI Insight|August 16, 2019
Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controllerStephen A Migueles, Cheryl Chairez, Siying Lin, et al.Journal of Virology|May 26, 2017
Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus MonkeysBoris Julg, Amarendra Pegu, Peter Abbink, et al.Plos Pathogens|March 26, 2015
Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimerRonald Derking, Gabriel Ozorowski, Kwinten Sliepen, et al.Mucosal Immunology|June 8, 2018
MAdCAM costimulation through Integrin-α<sub>4</sub>β<sub>7</sub> promotes HIV replicationFatima Nawaz, Livia R Goes, Jocelyn C Ray, et al.Ebiomedicine|July 3, 2015
CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen TypesStephen A Migueles, Daniel Mendoza, Matthew G Zimmerman, et al.Journal of Virology|January 9, 2009
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsivenessPrasanna Jagannathan, Christine M Osborne, Cassandra Royce, et al.Pageof 13